Serial echocardiographic changes in patients on hemodialysis: An evaluation of guideline implementation

Journal of Nephrology

Volumn 19, Issue 6, 2006, Pages 783-793

  Covic, Adrian ^a   Mardare, Nicoleta G I ^a   Ardeleanu, Serban ^a   Prisada, Octavian ^a   Gusbeth Tatomir, Paul ^a   Goldsmith, David J A ^b  

^a C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Chronic hemodialysis; Echocardiography; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; PARATHYROID HORMONE;

ADULT; AGED; ANEMIA; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ECG ABNORMALITY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION;

ECHOCARDIOGRAPHY; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 33947273727     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-69.
2. Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on Cardiovascular Disease. J Am Soc Nephrol 1998; 9 (Suppl 12): S31-42.
3. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in haemodialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-90.
4. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-54.
5. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996; 11: 1277-85.
6. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 2002; 40: 728-36.
7. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME. Alterations of left ventricular hypertrophy in and survival of patients receiving haemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-67.
8. Goldsmith DJ, Covic A. Coronary artery disease in patients with renal failure. Int J Clin Pract 2001; 55: 196-210.
9. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-8.
10. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-34.
11. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998; 54: 1720-5.
12. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS. Left ventricular mass monitoring in the follow-up of the dialysis patients: Prognostic value of LVH progression. Kidney Int 2004; 65: 1492-8.
13. Foley RN, Parfrey P, Kent G, Harnett JD, Murray DC, Barre P. Serial change in echocardiographic parameters and cardiac failure in end stage renal disease. J Am Soc Nephrol 2000; 11: 912-6.
14. Zoccali C, Benedetto FA, Tripepi G, Mallamaci F, Rapisarda F, Seminara G, Bonanno G, Malatino LS. Left ventricular systolic function monitoring in asymptomatic dialysis patients. J Am Soc Nephrol 2006; 17: 1460-5.
15. Parfrey P, Foley RN, Wittreich B, Sullivan D, Zagari M, Frei D. Double-blind comparison of full and partial anemia correction in incident haemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 2005; 16: 2180-9.
16. Kutlay S, Dincer I, Sengul S, Nergizoglu G, Duman N, Erturk S. Long term behavior and predictors of left ventricular hypertrophy in haemodialysis patients. Am J Kidney Dis 2006; 47: 485-92.
17. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA. Effect of hemoglobin levels in haemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325-35.
18. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving haemodialysis and epoetin. N Engl J Med 1998; 339: 584-90.
19. Mircescu G, Capsa D, Covic M, Caprioara MG, Gluhovschi G, Golea O, Ursea N, Garneata L, Cepoi V, Constantinovici N, Covic A. Nephrology and renal replacement therapy in Romania-transition still continues (Cinderella story revisited). Nephrol Dial Transplant 2004; 19: 2971-80.
20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
21. Pombo JF, Troy BL, Russell RO. Left ventricular volumes and ejection fraction by echocardiography. Circulation 1971; 43: 480-90,
22. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
23. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 2005; 46: 320-7.
24. Gaede P, Pedersen O. Intensive integrated therapy for type 2 diabetes mellitus. Implications for long term prognosis. Diabetes 2004; 53 (Suppl 3): S39-47.
25. Hampl H, Hennig L, Rosenberger C, Amirkhalily M, Gogoll L, Riedel E, Scherhag A. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients. Am J Nephrol 2005; 25: 211-20.
26. McMahon LP, Roger DS, Levin A. Development, prevention and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol 2004; 15: 1640-7.
27. Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal polycystic kidney disease: results of a seven years prospective randomized study. J Am Soc Nephrol 2002; 13: 1733-9.
28. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998; 13: 1489-93.
29. Frank H, Heusser K, Hoffken B, Huber P, Schmieder RE, Schobel HP. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients. Kidney Int 2004; 66: 832-40.
30. Macdougall IC. CREATE: new strategies for early anemia management in renal insufficiency. Nephrol Dial Transplant 2003; 18 (Suppl 2): II13-6.
31. Randon RB, Rohde LE, Comerlato L, Ribeiro JP, Manfro RC. The role of secondary hyperparathyroidism in left ventricular hypertrophy of patients under chronic haemodialysis. Braz J Med Biol Res 2005; 38: 1409-16.
32. Trovato GM, Iannetti E, Catalano D, Squatrito R, Vitale M, Zuccala G. Heart failure and nutritional status in haemodialysis. Recenti Prog Med 2001; 92: 655-9.